Market Overview
The global genotyping market size was valued at USD 18.58 billion in 2024 and is projected to grow from USD 21.24 billion in 2025 to reach USD 61.96 billion in 2033, growing at a CAGR of 14.32% during the forecast period (2025–2033). The market is being propelled by technological advances, falling DNA sequencing costs, and expanding...
The healthcare sector is becoming smarter and more data-driven, and precision medicine is at the center of this transformation. Patients today expect treatments tailored specifically to them, not generalized protocols. That expectation is fueling innovation across pharmaceutical research and clinical care.
Industry insights reveal that the Precision Medicine Market is gaining...
Precision medicine — the application of genomic, proteomic, metabolomic, and clinical data to tailor medical treatment to individual patient characteristics rather than population average responses — has transitioned from academic aspiration to clinical reality, with the Precision Medicine Market reflecting the commercial maturation of precision medicine across oncology, rare...
The US Precision Medicine Market isn’t just growing randomly. There are clear drivers pushing it forward. First, technological advancements in next-generation sequencing have made genetic testing faster and more affordable. This allows hospitals to integrate genomic insights into everyday clinical practice.
Second, government initiatives and funding programs are promoting personalized...
จองคิวบริการ
NR tours
Youplay
NR shop
NR jobs
facebook th
คลิกดาวน์โหลด
Spanish 
thai
English
French
Portuguese
Italiano
Romaian
Portuguese (Brazil)
china